Tulane University researchers have developed a CRISPR-based test that diagnoses Pneumocystis jirovecii pneumonia (PJP ... the Weatherhead Presidential Chair in Biotechnology Innovation and director of ...

The study, published in Nucleic Acids Research, introduces BLU-VIPR, a method that allows researchers to control the gene-editing tool CRISPR using light. This innovation could significantly ...

RAPID and accurate detection of bloodstream pathogens is essential for effective disease management, but current molecular ...

CRISPR Therapeutics (NasdaqGM:CRSP) recently announced the departure of Chief Operating Officer Julianne Bruno, reflecting a notable leadership change that could influence its operational direction.

Studies have demonstrated that CRISPR-based diagnostics can detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) within minutes, surpassing the efficiency of conventional PCR-based ...

Potential applications include infectious disease diagnostics, point-of-care testing, and personalized medicine. More ...

Beam Therapeutics said Monday that it used a form of CRISPR called base editing to correct, in several patients, a mutation that drives a debilitating lung condition that may affect tens of ...

Now, a new CRISPR-based test has been developed to ... and director of the Tulane Center for Cellular & Molecular Diagnostics, led a multidisciplinary team to develop the new tool, combining ...